Tumour cells produce receptor activator of NF-κB ligand (RANKL) in skeletal metastases

Lignende værker

• Receptor activator of NF-κB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment
  af: Huang, L, et al.
  Udgivet: (2003)
• Receptor Activator of NF-κB Ligand (RANKL) Protects Against Hepatic Ischemia/Reperfusion Injury in Mice
  af: Sakai, Nozomu, et al.
  Udgivet: (2012)
• RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice
  af: Fujiwara, Yuko, et al.
  Udgivet: (2016)
• Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
  af: Martin Widschwendter, et al.
  Udgivet: (2015-10-01)
• Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
  af: Widschwendter, Martin, et al.
  Udgivet: (2015)